Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Camp4 Therapeutics Q1 EPS $(0.62) Up From $(26.57) YoY, Sales $858.00K

Author: Benzinga Newsdesk | May 13, 2025 04:34pm
Camp4 Therapeutics (NASDAQ:CAMP) reported quarterly losses of $(0.62) per share. This is a 97.67 percent increase over losses of $(26.57) per share from the same period last year. The company reported $858.00 thousand in sales this quarter.

Posted In: CAMP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist